Leaflet VARILRIX LIVE ATTENUATED CHICKENPOX VACCINE 10^3.3 PFU / 0.5ml lyophilisate and solvent for solution for injection

Indicated for: prevention of varicella

Route of administration: injectable

Substance: live attenuated chickenpox vaccine (vaccine)

ATC: J07BK01 (Antiinfectives for systemic use | Viral vaccines | Varicella zoster vaccines)

Precautions:
Anaphylaxis
Anaphylaxis

Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.

Contraindicated during pregnancy
Contraindicated during pregnancy

Do not use this medicine during pregnancy.

Avoid live vaccines
Avoid live vaccines

Avoid live vaccines during treatment if contraindicated.

Additional monitoring
Additional monitoring

This medicine is subject to additional monitoring.

Refrigerated storage
Refrigerated storage

Store in the refrigerator as instructed in the leaflet.

Protect from light
Protect from light

Store protected from light.

The live attenuated varicella vaccine is used to prevent chickenpox, a highly contagious viral disease caused by the varicella-zoster virus (VZV). The vaccine contains a weakened form of the virus, which stimulates the immune system to produce antibodies against VZV, providing long-term protection against infection.

The vaccine is administered subcutaneously, usually in two doses, with the first dose given at 12-15 months of age and the second between 4 and 6 years. It is recommended for both children and adults who have not had chickenpox or been previously vaccinated.

Common side effects include redness, pain, or swelling at the injection site, mild fever, and rashes. In rare cases, severe allergic reactions or neurological complications may occur.

The live attenuated varicella vaccine is an effective preventive measure, helping to reduce the incidence of chickenpox and its associated complications, such as secondary bacterial infections and viral pneumonia.

General data about VARILRIX LIVE ATTENUATED CHICKENPOX VACCINE 10^3.3 PFU / 0.5ml

  • Substance: live attenuated chickenpox vaccine
  • Date of latest medicines list: 01-07-2013
  • Product code: W13412016
  • Concentration: 10^3.3 PFU / 0.5ml
  • Pharmaceutical form: lyophilisate and solvent for solution for injection
  • Quantity: 10
  • Product type: Generic medicine
  • Prescription status: P-RF - Medicines dispensed with a medical prescription that is retained by the pharmacy and cannot be renewed.